Member Info for Sock70

Completely disagree with delisting. Enormous potential in China with Bluehat status, together with our EFSA accreditation and the many gold standard studies. Transformation will begin after Bluehat and it's feasible Fruitflow will be an adjunct to other nutritionals and possibly drugs, such as Aspirin albeit hinges on a deal with major pharmaceutical due to cost of large scale studies. The product itself (Fruitflow) is gold standard. Spikey platelets cause so many health problems - blood pressure, blood flow, pollution toxicity, inflammation etc... We've got two out of 3 of the pillars of heart health - Blood pressure, Blood flow. I'm frustrated. In fact, very frustrated, but Bluehat in China in which we have a 1.4 billion population, Healthy China 2030, a prevention approach, high sports and natural supplement consciousness, and, I believe, biggest producer of tomatos in world. Plus, By-Health. Some years were wasted (agreed) not anymore. Plus FF smoothes platelets so Covid virus stands out more, meaning immune system can 'tag' the virus, attack and rid it from the human body.

Thanks, gixer :)

Thank you for the links :)

Is David from China about on this forum, as I'm keen to know exactly what Xinluosu means.

Does it literally mean natural Aspirin?

Thank you

I can see what you mean. It's been painful and taken a long time. Especially the SIS episode.

I had to average down from 6/8 pence, and still down on my investment, but this thing could absolutely fly in China's 1.4 billion population.

So much potential in China with Blue Hat status and fits into the Healthy China 2030 plan.

Extremely well scientifically substantiated product too.

Man, I've been waiting since 2009 as well. I hope with Blue Hat there will be take off.

It's such an appropriate time with Covid. I think FF would find its way as an adjunct with other dietary products.

It's hard to project how well it would do with Blue Hat status.

Does anybody have any graphs or statistics of sales increase of a novel product in China winning Blue Hat status?

gixer, thank you for all your hard work. Is it possible to have a brief summary of the health claims we are seeking and timeframes?

I know it's blood pressure, but I don't recall one for blood flow or cholesterol. I wondered what progress has been made on pollution too.

Thank you

Sock :)

Hi Gixer - It's Sock here. The Facebook link in your last message, who would have posted it? Is it Provexis who would have written it? Thanks

Thanks, gixer

Hi guys, wondered if anyone thinks we have put in a SAMR application get for Blue Hat?

Blood pressure & Covid-19

https://youtu.be/pq3dhtL8nio

lol! Classic. I forgot all about this. I can't remember who changed it to fit the PXS narrative. When PXS turns a corner, and sales in China boost the share price big time, a more up to date Downfall video can be made. On a separate note, for me, Downfall is one of the finest films ever made. Depressing subject (war, Nazi's etc...) but the best war film I've ever seen.

Is this a webinar that anyone can listen to?

PXS are processing my monthly renewal. I gotta say, I'm looking forward to seeing the new packaging.

Hi gixer, I know exactly zero about patent law, but it might be that PXS holds the main IP, and so not much Oslo can do with their patent.

I think Stuart Lucas knows the massive potential if a rare Blue-Cap claim antihypertensive supplement approval is achieved. With the exception of Chai tea (I think), I couldn't see any other Blue-Cap blood pressuring lowering supplements when I searched through China's equivalent to Amazon recently. Given hyperactive platelets are involved in so many biological systems, there will be a number of Blue-Cap's we can go for;

Aiding blood pressure reduction
Aiding blood lipids reduction
Relieving body fatigue
Facilitating lead excretion

We've got a lot of patents, and a lot of studies, all of which will help to win Blue-Cap status at a time when people in China (and everywhere) needs it.

I wouldn't be surprised if China fast track supplements that can be of some help during Covid-19.

Thank u, gixer. Seems like PXS hold the earliest patent, so that should hold us in good stead.

Yep. It's 5 studies that have been completed, according to last RNS. It's all positive stuff! This latest invention is so applicable to COVID-19. More studies needed though, but I expect them to be done as quickly as possible. As bad as it sounds, the pandemic is a big opportunity.

Cool... You'd think that it would be beneficial to get By-Health on board for this invention, given the air pollution in China. Not to mention the Chinese market. I would like to see a couple of studies in China, then a Blue cap claim. What are your thoughts?

Hi sphinx100, great find :) If studies go well with the FF composition, do you know how this would benefit us financially? It all seems to be entirely driven by DSM. Would there be a split of the profits?

Ditto!

...I managed to use Google translator on the website u kindly provided. I also put in the key words 'blood pressure' and 150 items appeared. A lot of them appear to be registrations that were approved 15 to 20 years ago. Perhaps these are old claims that don't have Blue Hats?